What We're Reading: FDA Says Novartis Hid Data; Judge Halts Ark. Abortion Rules; New Phase in Opioid Suits
Novartis hid manipulated data about its $2 million gene therapy Zolgensma from the FDA; US District Judge Kristine Baker granted a preliminary injunction preventing Arkansas from enforcing 3 abortion restrictions; a federal judge in Ohio expressed support for a plan by attorneys representing cities and counties suing US opioid manufacturers and distributors that would bring every US community into their settlement talks despite objections from most states.
Novartis Concealed Manipulated Data About Zolgensma Gene Therapy, FDA Says
Novartis hid manipulated data about its $2 million gene therapy Zolgensma from the FDA,
Arkansas’ 3 Abortion Restrictions Temporarily Blocked by Federal Judge
US District Judge Kristine Baker granted a preliminary injunction preventing Arkansas from enforcing 3 abortion restrictions,
Proposal in Opioid Lawsuits Envisions Adding US Counties, Municipalities to Plaintiff List
A federal judge in Ohio expressed support for a plan by attorneys representing cities and counties suing US opioid manufacturers and distributors that would bring every community nationally into their settlement talks despite objections from most states. US District Judge Dan Polster said the idea could allow the defendants accused of fueling the opioid crisis in nearly 2000 lawsuits before him the ability to obtain “global peace.”
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- ImmunoLogic, Episode 6: "The Future of Personalized Cancer Vaccines”
September 15th 2025
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025
- Duchenne Action Month 2025: Looking Back at News and Expert Insights
September 14th 2025
- CGTLive®’s Weekly Rewind – September 12, 2025
September 12th 2025